title: Embryonic signature in breast cancers; Pluripotency roots of cancer stem cells.
abstract: Drug discovery programs for preclinical oncology typically select compounds which have a predilection for inducing cytotoxic effects in cancer cell lines and subsequently, for inhibiting the growth of the transplanted cancer cells in vivo (Winquist et al., 2010). Unfortunately, the cytotoxic effect in vitro and inhibition of tumor growth in animal models are not the end story for curing cancer in preclinical models. The reason behind that is the exciting of small sub type of cells that are relatively resistance to therapy and able to repopulate in vivo, called cancer stem cells (CSCs). O leis et al. recently reported that the pluripotency gene Sox2 but not Oct4 or Nanog is expressed in early stage of breast tumor. Furthermore, the authors demonstrated that Sox2 downregulation, inhibited mammosphere formation and delayed tumor formation in xenograft tumor initiation models (Leis et al., 2012). In this review, we will shed the light on the importance of Sox2 in breast and other tissue tumorigenesis and associated aggressiveness.
authors: Stem Cell Therapy Program, King Faisal Specialized Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
authors: Abdullah
authors: A
authors: Al-Dhfyan
keywords: ALDH, aldehyde dehydrogenase; Breast tumorigenesis; CSCs, cancer stem cells; Cancer stem cells (CSCs); GSK, glycogen synthase kinase; Pluripotency gene; SP, side population cells
references: Front Biosci (Landmark Ed). 2011 Jan 01;16:1927-38
references: 21196274
references: Mod Pathol. 2007 Apr;20(4):474-81
references: 17334350
references: Cell. 2007 Dec 14;131(6):1109-23
references: 18083101
references: Nature. 2007 Jan 4;445(7123):111-5
references: 17122771
references: Cell Stem Cell. 2007 Nov;1(5):555-67
references: 18371393
references: Eur J Cancer. 1999 May;35(5):711-3
references: 10505029
references: J Cell Biol. 2000 Feb 7;148(3):567-78
references: 10662781
references: Genes Dev. 1997 Dec 15;11(24):3286-305
references: 9407023
references: Nat Genet. 2008 May;40(5):499-507
references: 18443585
references: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4198-203
references: 10760287
references: Int J Cancer. 2000 Jun 1;86(5):652-9
references: 10797286
references: Curr Opin Cell Biol. 1999 Apr;11(2):233-40
references: 10209158
references: Development. 2004 Jun;131(12):2803-15
references: 15142971
references: Trends Genet. 2000 Apr;16(4):182-7
references: 10729834
references: Br J Cancer. 2011 Apr 26;104(9):1410-7
references: 21468047
references: Dev Cell. 2009 Jul;17(1):9-26
references: 19619488
references: Nature. 2005 Jul 28;436(7050):518-24
references: 16049480
references: Br J Cancer. 2010 Aug 10;103(4):439-45
references: 20664590
references: J Natl Cancer Inst. 2008 May 7;100(9):672-9
references: 18445819
references: Pancreas. 2006 Mar;32(2):164-70
references: 16552336
references: Cancer Res. 2007 May 15;67(10):4827-33
references: 17510412
references: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references: 12629218
references: Curr Opin Genet Dev. 2002 Aug;12(4):441-6
references: 12100890
references: Cancer Res. 2003 Sep 15;63(18):5821-8
references: 14522905
references: Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9601-6
references: 15983380
references: Nat Med. 1997 Jul;3(7):730-7
references: 9212098
references: Neuron. 2005 Apr 7;46(1):23-36
references: 15820691
references: Cancer Res. 2005 Jul 15;65(14):6207-19
references: 16024622
references: Development. 2004 Apr;131(8):1663-77
references: 15084453
references: Br J Cancer. 2008 Feb 26;98(4):824-31
references: 18268498
references: Cancer Sci. 2009 Jun;100(6):1062-8
references: 19385968
references: Oncogene. 2012 Mar 15;31(11):1354-65
references: 21822303
references: Mol Oncol. 2010 Oct;4(5):404-19
references: 20599450
references: J Biol Chem. 2008 Jun 27;283(26):17969-78
references: 18456656
references: Clin Cancer Res. 2009 Jun 15;15(12):4234-41
references: 19509181
references: Neuron. 2003 Aug 28;39(5):749-65
references: 12948443
references: Curr Opin Pharmacol. 2010 Aug;10(4):385-90
references: 20630801
references: Nucleic Acids Res. 1999 Mar 15;27(6):1409-20
references: 10037800
references: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
references: 14711994
references: J Mol Cell Biol. 2011 Aug;3(4):230-8
references: 21415100
references: Clin Cancer Res. 2010 Jan 1;16(1):45-55
references: 20028757
references: BMC Cancer. 2011 Jan 28;11:42
references: 21276239